Global Companion Diagnostic Tests in Oncology Market Status and Outlook 2022-2027

Code: RW00014862112
Multimarket Insight
Sep-2022
Technology, Media, & Telecommunications
108 Pages

A test used to help match a patient to a specific drug or therapy.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Companion Diagnostic Tests in Oncology industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Protein Detection
DNA Detection
Hybridization
Biomarker
Others

Market Segment by Product Application
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes

Finally, the report provides detailed profile and data information analysis of leading company.
F. Hoffman LA Roche Ltd.
Siemens Healthcare GmBH
Agilent Technologies, Inc.
QIAGEN, Illumina, Inc.
AGENDIA NV
Abbott
BioMerieux SA, BioGenex
Genomic Health, Inc.
Thermo Fisher Scientific, Inc.

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Companion Diagnostic Tests in Oncology consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Companion Diagnostic Tests in Oncology market by identifying its various subsegments.
3.Focuses on the key global Companion Diagnostic Tests in Oncology manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Companion Diagnostic Tests in Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Companion Diagnostic Tests in Oncology submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Companion Diagnostic Tests in Oncology Market Status and Outlook 2022-2027

Market Study Overview
1.1 Study Objectives
1.2 Companion Diagnostic Tests in Oncology Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Companion Diagnostic Tests in Oncology Segment by Type
2.1.1 Protein Detection
2.1.2 DNA Detection
2.1.3 Hybridization
2.1.4 Biomarker
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Pharmaceutical and Biotechnology Companies
2.2.2 Medical Device Companies
2.2.3 Research Institutes
2.3 Global Companion Diagnostic Tests in Oncology Market Comparison by Regions (2017-2027)
2.3.1 Global Companion Diagnostic Tests in Oncology Market Size (2017-2027)
2.3.2 North America Companion Diagnostic Tests in Oncology Status and Prospect (2017-2027)
2.3.3 Europe Companion Diagnostic Tests in Oncology Status and Prospect (2017-2027)
2.3.4 Asia-pacific Companion Diagnostic Tests in Oncology Status and Prospect (2017-2027)
2.3.5 South America Companion Diagnostic Tests in Oncology Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Companion Diagnostic Tests in Oncology Status and Prospect (2017-2027)
2.5 Coronavirus Disease 2019 (Covid-19): Companion Diagnostic Tests in Oncology Industry Impact
2.5.1 Companion Diagnostic Tests in Oncology Business Impact Assessment - Covid-19
2.5.2 Market Trends and Companion Diagnostic Tests in Oncology Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Vendors
3.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Vendors (2017-2022)
3.2 Global Companion Diagnostic Tests in Oncology Industry Concentration Ratio (CR5 and HHI)
3.3 Top 5 Companion Diagnostic Tests in Oncology Vendors Market Share
3.4 Top 10 Companion Diagnostic Tests in Oncology Vendors Market Share
3.5 Date of Key Vendors Enter into Companion Diagnostic Tests in Oncology Market
3.6 Key Vendors Companion Diagnostic Tests in Oncology Product Offered
3.7 Mergers & Acquisitions Planning

4 Analysis of Companion Diagnostic Tests in Oncology Industry Key Vendors
4.1 F. Hoffman LA Roche Ltd.
4.1.1 Company Details
4.1.2 Product Introduction, Application and Specification
4.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 F. Hoffman LA Roche Ltd. News
4.2 Siemens Healthcare GmBH
4.2.1 Company Details
4.2.2 Product Introduction, Application and Specification
4.2.3 Siemens Healthcare GmBH Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Siemens Healthcare GmBH News
4.3 Agilent Technologies, Inc.
4.3.1 Company Details
4.3.2 Product Introduction, Application and Specification
4.3.3 Agilent Technologies, Inc. Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Agilent Technologies, Inc. News
4.4 QIAGEN, Illumina, Inc.
4.4.1 Company Details
4.4.2 Product Introduction, Application and Specification
4.4.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 QIAGEN, Illumina, Inc. News
4.5 AGENDIA NV
4.5.1 Company Details
4.5.2 Product Introduction, Application and Specification
4.5.3 AGENDIA NV Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 AGENDIA NV News
4.6 Abbott
4.6.1 Company Details
4.6.2 Product Introduction, Application and Specification
4.6.3 Abbott Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Abbott News
4.7 BioMerieux SA, BioGenex
4.7.1 Company Details
4.7.2 Product Introduction, Application and Specification
4.7.3 BioMerieux SA, BioGenex Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 BioMerieux SA, BioGenex News
4.8 Genomic Health, Inc.
4.8.1 Company Details
4.8.2 Product Introduction, Application and Specification
4.8.3 Genomic Health, Inc. Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Genomic Health, Inc. News
4.9 Thermo Fisher Scientific, Inc.
4.9.1 Company Details
4.9.2 Product Introduction, Application and Specification
4.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests in Oncology Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Thermo Fisher Scientific, Inc. News

5 Global Companion Diagnostic Tests in Oncology Market Size Categorized by Regions
5.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Regions
5.2 North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
5.3 Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
5.4 Asia-pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
5.5 South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
5.6 Middle East & Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)

6 North America Companion Diagnostic Tests in Oncology Market Size Categorized by Countries
6.1 North America Companion Diagnostic Tests in Oncology Revenue and Market Share by Countries
6.1.1 North America Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
6.1.2 United States Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
6.1.3 Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
6.1.4 Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
6.2 North America Companion Diagnostic Tests in Oncology Revenue (Value) by Vendors
6.3 North America Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2017-2022)
6.4 North America Companion Diagnostic Tests in Oncology Revenue and Market Share by Application (2017-2022)

7 Europe Companion Diagnostic Tests in Oncology Market Size Categorized by Countries
7.1 Europe Companion Diagnostic Tests in Oncology Revenue and Market Share by Countries
7.1.1 Europe Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
7.1.2 Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
7.1.3 UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
7.1.4 France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
7.1.5 Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
7.1.6 Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
7.1.7 Spain Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
7.2 Europe Companion Diagnostic Tests in Oncology Revenue (Value) by Vendors
7.3 Europe Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2017-2022)
7.4 Europe Companion Diagnostic Tests in Oncology Revenue and Market Share by Application (2017-2022)

8 Asia-pacific Companion Diagnostic Tests in Oncology Market Size Categorized by Countries
8.1 Asia-pacific Companion Diagnostic Tests in Oncology Revenue and Market Share by Countries
8.1.1 Asia-pacific Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
8.1.2 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
8.1.3 South Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
8.1.4 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
8.1.5 Australia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
8.1.6 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
8.1.7 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
8.2 Asia-pacific Companion Diagnostic Tests in Oncology Revenue (Value) by Vendors
8.3 Asia-pacific Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2017-2022)
8.4 Asia-pacific Companion Diagnostic Tests in Oncology Revenue and Market Share by Application (2017-2022)

9 South America Companion Diagnostic Tests in Oncology Market Size Categorized by Countries
9.1 South America Companion Diagnostic Tests in Oncology Revenue and Market Share by Countries
9.1.1 South America Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
9.1.2 Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
9.1.3 Chile Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
9.2 South America Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2017-2022)
9.3 South America Companion Diagnostic Tests in Oncology Revenue and Market Share by Application (2017-2022)

10 Middle East and Africa Companion Diagnostic Tests in Oncology Market Size Categorized by Countries
10.1 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Market Share by Countries
10.1.1 Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
10.1.2 GCC Countries Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
10.1.3 Turkey Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
10.1.4 Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
10.1.5 South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
10.2 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Market Share by Type
10.3 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2017-2022)

11 Global Companion Diagnostic Tests in Oncology Market Segment by Type
11.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2017-2022)
11.2 Protein Detection Revenue Growth Rate and Price
11.3 DNA Detection Revenue Growth Rate and Price
11.4 Hybridization Revenue Growth Rate and Price
11.5 Biomarker Revenue Growth Rate and Price
11.6 Others Revenue Growth Rate and Price

12 Global Companion Diagnostic Tests in Oncology Market Segment by Application
12.1 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2017-2022)
12.2 Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2017-2022)
12.3 Medical Device Companies Revenue Growth Rate (2017-2022)
12.4 Research Institutes Revenue Growth Rate (2017-2022)

13 Global Companion Diagnostic Tests in Oncology Market Forecast
13.1 Global Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2022-2027)
13.2 Companion Diagnostic Tests in Oncology Market Forecast by Regions (2022-2027)
13.2.1 North America Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
13.2.2 Europe Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
13.2.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
13.2.4 South America Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
13.2.5 Middle East & Africa Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
13.3 Companion Diagnostic Tests in Oncology Market Forecast by Type (2022-2027)
13.3.1 Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2022-2027)
13.3.2 Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2022-2027)
13.4 Companion Diagnostic Tests in Oncology Market Forecast by Application (2022-2027)
13.4.1 Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Downstream Market Analysis
15.1 Macro Analysis of Down Markets
15.2 Key Players in Down Markets

16 Research Findings and Conclusion

List of Tables and Figures

Figure Product Picture Companion Diagnostic Tests in Oncology
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Companion Diagnostic Tests in Oncology Market Size (Million US$) by Type
Figure Global Market Share of Companion Diagnostic Tests in Oncology by Type in 2021
Figure Protein Detection Picture
Figure DNA Detection Picture
Figure Hybridization Picture
Figure Biomarker Picture
Figure Others Picture
Table Global Companion Diagnostic Tests in Oncology Market Size (Million US$) by Application
Figure Global Companion Diagnostic Tests in Oncology Market Share by Application in 2021
Figure Pharmaceutical and Biotechnology Companies Picture
Figure Medical Device Companies Picture
Figure Research Institutes Picture
Table Global Companion Diagnostic Tests in Oncology Comparison by Regions (M USD) 2017-2027
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million US$) (2017-2027)
Figure North America Companion Diagnostic Tests in Oncology Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Companion Diagnostic Tests in Oncology Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Companion Diagnostic Tests in Oncology Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Companion Diagnostic Tests in Oncology Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Companion Diagnostic Tests in Oncology Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Companion Diagnostic Tests in Oncology Revenue by Vendors (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Vendors in 2021
Table Global Companion Diagnostic Tests in Oncology Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Companion Diagnostic Tests in Oncology Vendors (Revenue) Market Share in 2021
Figure Top 10 Companion Diagnostic Tests in Oncology Vendors (Revenue) Market Share in 2021
Table Date of Key Vendors Enter into Companion Diagnostic Tests in Oncology Market
Table Key Vendors Companion Diagnostic Tests in Oncology Product Type
Table F. Hoffman LA Roche Ltd. Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of F. Hoffman LA Roche Ltd.
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of F. Hoffman LA Roche Ltd. 2017-2022
Table F. Hoffman LA Roche Ltd. Main Business
Table F. Hoffman LA Roche Ltd. Recent Development
Table Siemens Healthcare GmBH Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of Siemens Healthcare GmBH
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of Siemens Healthcare GmBH 2017-2022
Table Siemens Healthcare GmBH Main Business
Table Siemens Healthcare GmBH Recent Development
Table Siemens Healthcare GmBH Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of Siemens Healthcare GmBH
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of Siemens Healthcare GmBH 2017-2022
Table Siemens Healthcare GmBH Main Business
Table Siemens Healthcare GmBH Recent Development
Table Agilent Technologies, Inc. Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of Agilent Technologies, Inc.
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of Agilent Technologies, Inc. 2017-2022
Table Agilent Technologies, Inc. Main Business
Table Agilent Technologies, Inc. Recent Development
Table QIAGEN, Illumina, Inc. Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of QIAGEN, Illumina, Inc.
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of QIAGEN, Illumina, Inc. 2017-2022
Table QIAGEN, Illumina, Inc. Main Business
Table QIAGEN, Illumina, Inc. Recent Development
Table AGENDIA NV Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of AGENDIA NV
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of AGENDIA NV 2017-2022
Table AGENDIA NV Main Business
Table AGENDIA NV Recent Development
Table Abbott Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of Abbott
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of Abbott 2017-2022
Table Abbott Main Business
Table Abbott Recent Development
Table BioMerieux SA, BioGenex Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of BioMerieux SA, BioGenex
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of BioMerieux SA, BioGenex 2017-2022
Table BioMerieux SA, BioGenex Main Business
Table BioMerieux SA, BioGenex Recent Development
Table Genomic Health, Inc. Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of Genomic Health, Inc.
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of Genomic Health, Inc. 2017-2022
Table Genomic Health, Inc. Main Business
Table Genomic Health, Inc. Recent Development
Table Thermo Fisher Scientific, Inc. Company Profile
Table Companion Diagnostic Tests in Oncology Product Introduction, Application and Specification of Thermo Fisher Scientific, Inc.
Table Companion Diagnostic Tests in Oncology Revenue (M USD) and Gross Margin of Thermo Fisher Scientific, Inc. 2017-2022
Table Thermo Fisher Scientific, Inc. Main Business
Table Thermo Fisher Scientific, Inc. Recent Development
Table Mergers & Acquisitions Planning
Figure Global Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Revenue by Regions (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions in 2021
Figure North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Asia-pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table North America Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
Table North America Companion Diagnostic Tests in Oncology Market Share by Countries (2017-2022)
Figure North America Companion Diagnostic Tests in Oncology Market Share by Countries in 2021
Figure United States Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table North America Companion Diagnostic Tests in Oncology Revenue by Vendors (2021)
Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Vendors in 2021
Table North America Companion Diagnostic Tests in Oncology Revenue by Type (2017-2022)
Table North America Companion Diagnostic Tests in Oncology Share by Type (2017-2022)
Table North America Companion Diagnostic Tests in Oncology Revenue by Application (2017-2022)
Table North America Companion Diagnostic Tests in Oncology Revenue Share by Application (2017-2022)
Figure Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table Europe Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
Table Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2017-2022)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2021
Figure Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Spain Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table Europe Companion Diagnostic Tests in Oncology Revenue by Vendors (2021)
Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Vendors in 2021
Table Europe Companion Diagnostic Tests in Oncology Revenue by Type (2017-2022)
Table Europe Companion Diagnostic Tests in Oncology Revenue Share by Type (2017-2022)
Table Europe Companion Diagnostic Tests in Oncology Revenue by Application (2017-2022)
Table Europe Companion Diagnostic Tests in Oncology Revenue Share by Application (2017-2022)
Figure Asia-pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table Asia-pacific Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
Table Asia-pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2021
Figure China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure South Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Australia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table Asia-pacific Companion Diagnostic Tests in Oncology Revenue by Vendors (2021)
Figure Asia-pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Vendors in 2021
Table Asia-pacific Companion Diagnostic Tests in Oncology Revenue by Type (2017-2022)
Table Asia-pacific Companion Diagnostic Tests in Oncology Revenue Share by Type (2017-2022)
Table Asia-pacific Companion Diagnostic Tests in Oncology Revenue by Application (2017-2022)
Table Asia-pacific Companion Diagnostic Tests in Oncology Revenue Share by Application (2017-2022)
Figure South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table South America Companion Diagnostic Tests in Oncology Revenue Market Size by Countries (2017-2022)
Table South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2017-2022)
Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2019
Figure Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Chile Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table South America Companion Diagnostic Tests in Oncology Revenue s by Type (2017-2022)
Table South America Companion Diagnostic Tests in Oncology Revenue Share by Type (2017-2022)
Table South America Companion Diagnostic Tests in Oncology Revenue by Application (2017-2022)
Table South America Companion Diagnostic Tests in Oncology Revenue Share by Application (2017-2022)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Countries (2017-2022)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Companion Diagnostic Tests in Oncology Sales Market Share by Countries in 2019
Figure GCC Countries Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Turkey Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Figure South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue by Type (2017-2022)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Share by Type (2017-2022)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue by Application (2017-2022)
Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Share by Application (2017-2022)
Table Global Companion Diagnostic Tests in Oncology Revenue by Type (2017-2022)
Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type in 2019
Figure Global Protein Detection Revenue and Growth Rate (2017-2022)
Figure Global DNA Detection Revenue and Growth Rate (2017-2022)
Figure Global Hybridization Revenue and Growth Rate (2017-2022)
Figure Global Biomarker Revenue and Growth Rate (2017-2022)
Figure Global Others Revenue and Growth Rate (2017-2022)
Table Global Companion Diagnostic Tests in Oncology Revenue by Application (2017-2022)
Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application in 2021
Figure Global Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2017-2022)
Figure Global Medical Device Companies Revenue Growth Rate (2017-2022)
Figure Global Research Institutes Revenue Growth Rate (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2022-2027)
Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Regions (2022-2027)
Table Global Companion Diagnostic Tests in Oncology Market Share Forecast by Regions (2022-2027)
Figure North America Revenue Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
Figure Europe Revenue Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
Figure Asia-Pacific Revenue Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
Figure South America Revenue Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
Figure Middle East & Africa Revenue Companion Diagnostic Tests in Oncology Market Forecast (2022-2027)
Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2022-2027)
Table Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2022-2027)
Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2022-2027)
Table Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Author List

F. Hoffman LA Roche Ltd.
Siemens Healthcare GmBH
Agilent Technologies, Inc.
QIAGEN, Illumina, Inc.
AGENDIA NV
Abbott
BioMerieux SA, BioGenex
Genomic Health, Inc.
Thermo Fisher Scientific, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Brain-inspired Computing Market G.. The global market for Brain-inspired Computing is estimated ..

Global SMEs Employee Engagement Software.. The global market for SMEs Employee Engagement Software is e..

Global Animal Feed Analysis Service Mark.. The global market for Animal Feed Analysis Service is estima..

Global Animal Feed Safety Inspection Ser.. The global market for Animal Feed Safety Inspection Service ..

Global Contactless Touch Technology Mark.. The global market for Contactless Touch Technology is estima..

Global Battery Manufacturing Software Ma.. The global market for Battery Manufacturing Software is esti..

Global Fiber Optic Grommet Market Growth.. The global market for Fiber Optic Grommet is estimated to in..

Global Flexible High Transmittance Anten.. The global market for Flexible High Transmittance Antenna is..

Global Low Frequency Omnidirectional Ant.. The global market for Low Frequency Omnidirectional Antenna ..

Global High Frequency Omnidirectional An.. The global market for High Frequency Omnidirectional Antenna..

Global Institutional Consulting Market G.. The global market for Institutional Consulting is estimated ..

Global Enterprise Mailbox Market Growth .. The global market for Enterprise Mailbox is estimated to inc..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE